About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 50 record(s)
Req # A-2021-00217
Briefing Note PSD155: Options for Governance of Missing and Murdered Indigenous Women and Girls National Action Plan Implementation.Organization: Crown-Indigenous Relations and Northern Affairs Canada
March 2022
Req # A-2021-02306
A document commissioned by ECCC in 2015 on “French names of Canada’s molluscs”Organization: Environment and Climate Change Canada
March 2022
Req # A-2021-001600
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the proposed Certified Product Information Document.Organization: Health Canada
February 2022
Req # A-2021-001601
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the “Batch Formula” (3.2.P.3.2).Organization: Health Canada
February 2022
Req # A-2021-001602
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the “Description of Manufacturing Process and Process Controls” (3.2.P.3.3).Organization: Health Canada
February 2022
Req # A-2021-001605
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the proposed Product Monograph.Organization: Health Canada
February 2022
Req # A-2020-00513
A copy of briefing note MIN – 264897Organization: Environment and Climate Change Canada
January 2022
Req # A-2021-01160
Copies of Briefing notes MIN – 275522, 279523, 275423, 277866, 278155, 278368, 278967, 277928 & DM – 279270, 280029, 279932Organization: Environment and Climate Change Canada
January 2022
Req # A-2021-24151
All data source files used to produce the CompassRx 7th Edition Annual Public Drug Plan Expenditure Report, 2019/20, published November 2021 and available here:https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/compassrx-7th-edition.html and here:https://www.canada.ca/content/dam/pmprb-cepmb/documents/npduis/analytical-studies/compassrx-7th-edition/NPDUIS-CompassRx7th-2019-2020_en.pdf.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-00074
All documents regarding agreements the Metis Nation of Alberta has with the Government of Canada from January 1, 2015 to present. Specifically, any funding agreements the Metis Nation of Alberta has directly or through its affiliates (Rupertsland Institute, Metis Housing Corporation). Additionally, any agreements or stipulations the Metis Nation of Alberta had with respect to funding received as a result of the COVID-19 pandemic.Organization: Crown-Indigenous Relations and Northern Affairs Canada
November 2021